logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Innovation And Commercialisation In The Biopharmaceutical Industry Creating And Capturing Value Bruce Rasmussen

  • SKU: BELL-1663104
Innovation And Commercialisation In The Biopharmaceutical Industry Creating And Capturing Value Bruce Rasmussen
$ 31.00 $ 45.00 (-31%)

4.0

56 reviews

Innovation And Commercialisation In The Biopharmaceutical Industry Creating And Capturing Value Bruce Rasmussen instant download after payment.

Publisher: Edward Elgar Pub
File Extension: PDF
File size: 2.95 MB
Pages: 335
Author: Bruce Rasmussen
ISBN: 9781848447172, 1848447175
Language: English
Year: 2010

Product desciption

Innovation And Commercialisation In The Biopharmaceutical Industry Creating And Capturing Value Bruce Rasmussen by Bruce Rasmussen 9781848447172, 1848447175 instant download after payment.

This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book. The author shows that while traditional pharmaceutical companies have successfully adjusted their business models to meet the challenges of biotechnology, biopharmaceutical start-ups have experienced more problems. Despite the poor financial performance of the vast majority of these firms, the biopharmaceutical sector as a whole has created significant value. However, this has been captured disproportionately by a handful of large, fully-integrated biopharmaceutical firms and, to a lesser extent, by the largest dozen pharmaceutical companies. This highly focused book will be a captivating read for innovation and biopharmaceutical industry analysts, as well as advisers formulating policies to support the development of the biopharmaceutical sector. Academics working on innovation and biotechnology, as well as scientists engaged in research in the life sciences, will also find this book of particular interest.

Related Products